About ProCell
ProCell is a company based in Canton (United States) founded in 2015. It operates as a B2B. ProCell offers products and services including Pro Cell. ProCell operates in a competitive market with competitors including Haemonetics, VISIE, Sisu Global Health, Scinovia and Haermonics, among others.
- Headquarter Canton, United States
- SectorsHealthcare
- Email••••••••
- Website procellsi.com
- Social LinkedIn
- Legal Name Procell Surgical Inc.
Products & Services of ProCell
ProCell offers a comprehensive portfolio of products and services, including Pro Cell.
Automates blood recovery from surgical sponges for autotransfusion.
Competitors of ProCell
ProCell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Haemonetics, VISIE, Sisu Global Health, Scinovia and Haermonics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| haemonetics.com | 1971 | Braintree, United States | – | 3,034 | Hematology products and solutions are provided for medical applications. | |
| visievision.com | 2017 | Austin, United States | $12.71M | – | Provider of 3D intraoperative imaging technology for orthopedic, neuro, and spine surgery | |
| sisuglobal.health | 2014 | Baltimore, United States | – | – | Intraoperative autotransfusion devices are developed and provided. | |
| scinovia.com | 2014 | Durham, United States | $6.91M | 10 | Augmented-reality surgical cameras for blood flow visualization are developed. | |
| haermonics.com | 2015 | Amsterdam, Netherlands | $4.41M | – | Postoperative pericardial drainage and flushing system is developed. | |
| i-sep.com | 2015 | Nantes, France | $3.61M | – | Cell salvage solutions for autologous blood transfusion during surgery | |
| perfusio.com | 2014 | Greenville, United States | $7.79M | – | Blood-flow imaging devices for surgical procedures are developed. | |
| swabtech.co.uk | 2012 | Manchester, United Kingdom | $938,127 | – | Offers a device for intra-operative blood recovery from swabs. | |
| gatescience.com | 2020 | Boston, United States | $150,000 | – | Developer of a multi-modal device for post-surgery pain |
Detailed competitors of ProCell
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ProCell
The website of ProCell (procellsi.com) receives about 2.8K visits a month.
- Monthly visits2.8K
▲ 50.7% vs previous month
Latest news on Procell
Complete news archive for ProCell
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to ProCell
10 companies that operate in the same segment as ProCell (Wound Care), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanotech-based wound care products are developed and provided. | 2010 | Madison, Wisconsin, United States | USD 22.7 M | – | 35 | |
Fish-skin acellular dermal matrix technology is provided for wound treatments. | 2007 | Isafjordur, Iceland | USD 93.11 M | – | 150 | |
Developer of advanced haemostat and wound care dressing products | 2008 | Ahmedabad, Gujarat, India | USD 42.71 M | USD 2.88 M | 70 | |
Oxygen-based wound therapy devices are developed for healing non-healing wounds. | 2003 | Waterbeach, Cambridgeshire, United Kingdom | USD 68.39 M | – | – | |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics | 1985 | Marietta, Georgia, United States | – | USD 418.63 M | 837 | |
Biological drugs for skin and mucosa wound treatment are developed. | 2016 | Uppsala, Uppsala County, Sweden | USD 4.02 M | USD 1.12 M | – | |
Developer of hemostatic products for wound care | 2010 | New York, New York, United States | USD 113.35 M | – | – | |
Regenerative therapies for wound care are developed and commercialized. | 1985 | Canton, Ohio, United States | USD 30 M | USD 564.17 M | 869 | |
Cold plasma solutions for wound treatment are developed. | 2013 | Eindhoven, Noord-brabant, Netherlands | USD 7.06 M | – | – | |
Point-of-care devices for wound bacterial assessment are provided. | 2013 | Toronto, Ontario, Canada | USD 43.2 M | – | 49 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ProCell
ProCell was founded in 2015.
ProCell is headquartered in Canton, United States. It is registered at Canton, Ohio, United States.
ProCell Surgical Inc. creates and sells automated medical devices that recover blood from surgical sponges to support intraoperative autotransfusion, enhancing patient outcomes and reducing costs. The company operates by optimizing blood conservation through efficient fluid recovery and improved workflow safety. Based in Canton, Massachusetts, it serves healthcare providers with innovative tools for surgical settings, focusing on ergonomic and effective solutions without promotional emphasis.
ProCell's top competitors include Haemonetics, VISIE and Sisu Global Health.
ProCell offers Pro Cell.
ProCell operates through Procell Surgical Inc..